PPD Launches Innovative Web-based Technology to Analyze Near Real-time Global Central Lab Data

Business Wire,  June 23, 2008  

• E-mail
• Print
• Link

WILMINGTON, N.C. -- PPD, Inc. (Nasdaq: PPDI) today announced it has launched PPD Clicks[TM], a secure Web site to provide clients with near real-time lab data from its global central lab facilities in Highland Heights, Ky.; Brussels, Belgium; and Beijing, China.

Central lab results from all PPD analyzers worldwide are instantly available in a single global database and minutes thereafter on PPD Clicks. The site gives clients immediate, easy access to their single-source global and combinable lab data through a standard Web browser and Internet access.

Available to all PPD global central lab clients as part of its database services, PPD Clicks allows users to sort and view data by site, tests or alerts; narrow searches using custom filters; and find detailed results for each study subject. The intuitive, user-friendly Web site easily allows clients to create, view, schedule and distribute customized reports to analyze comprehensive study information.

"The high-end technology of PPD Clicks is built upon our proven proprietary enterprise application and offers clients a dynamic, scalable and robust platform to meet their growing clinical trial information management needs," said Agostino Fede, Ph.D., senior vice president at PPD and head of global central labs. "A truly single global database featuring intuitive navigation and a high level of easy, self-service customization ensures that our clients have secure, anytime, anywhere access to their data."

PPD Clicks is immediately available to all clients. Approximately one-third of the company's global central lab studies are already running on the new platform.

PPD is a leading global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 31 countries and more than 10,400 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients. For more information, visit our Web site at http://www.ppdi.com.

Except for historical information, all of the statements, expectations and assumptions contained in this news release, including expectations and assumptions about the performance and value of this technology, are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors which could cause results to differ materially include the following: rapid technological advances that make our products and services less competitive; competition within the outsourcing industry; continued success in sales growth; loss of large contracts; increased cancellation rates; economic conditions and outsourcing trends in the pharmaceutical, biotechnology, medical device, academic and government industry segments; the ability to attract and retain key personnel; risks associated with and dependence on collaborative relationships; risks associated with the development and commercialization of drugs, including earnings dilution and obtaining regulatory approval; risks associated with acquisitions and investments, such as impairments; risks that we may not continue our dividend policy; and the other risk factors set forth from time to time in the SEC filings for PPD, copies of which are available free of charge upon request from the PPD investor relations department.

COPYRIGHT 2008 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning